Infectious Diseases Flashcards
What is tuberculosis
A contagious, debilitating (consuming) bacterial disease spread by airborne droplets
Coughing, speaking, sneezing
Left untreated, one person with tuberculosis will infect 10-15 people (R0)
What bacterium causes tuberculosis
Mycobacterium tuberculosis
Slow growing, difficult to kill, waxy coat
What imaging test can detect TB
X-ray showing multiple cavities, also lungs can undergo necrosis
What is a TB granuloma
Chronic granulomatous inflammatory responses
In the centre it is necrotic and liquified leading to cavities
Bacteria can grow in these cavities which may be released into the bronchus, coughed and spread
How many people with TB present with symptoms
Exposure - only 30% get infection - of this 5% progress to active disease while 90% have latent TB
How can you detect latent TB
A mantoux test (injection of TB Abs) shows reaction in latent infection
When is TB latency problematic
When the person is immunosuppressed
Why can TB become quickly resistant
High bacterial load in TB (unique) = many organisms, that can eventually gain resistance
How do you treat TB
Antibiotics - firstly streptomycin, however TB rapidly became resistant to this
4 drug combination trial - standard short course of 4 drugs for 6 months
Overcomes mutation rates, 95% effective with relapse rate 3-4%
Treatment must contain multiple drugs to which organisms are susceptible
What is the phases and drugs used in treatment of TB
Intensive phase - RHZE for 2 months
Continuous phase - RH for 4 months
Can last longer e.g. when infection of meninges
What drugs are used to treat TB
Isoniazid (INH/H) Rifampicin (RIF/R)
Pyrazinamide (PZA/Z)
Ethambutol (EMB/E)
What is the mechanism of action for isoniazid
Isoniazid (INH/H) – inhibits synthesis of mycolic acid, required for mycobacterial cell wall
What is the mechanism of action for rifampicin
It inhibits bacterial RNA polymerase
What is the mechanism of action for pyrazinamide
It binds to the ribosomal protein S1 (RpsA) and inhibits translation + other possible mechanisms
What is the mechanism of action for ethambutol
It inhibits arabinosyl transferases involved in cell wall biosynthesis of arabinogalactans
What is the molecular mode of action of isoniazid
Analogue of nicotinic acid
It’s a prodrug that is activated by catalase peroxidase inside the bacteria produced by KatG
This then adducts with Iso-NADH, binding the lipid synthetase preventing mycolic acid synthesis
These enzymes are coded by Inh A
What is the molecular mode of action of isoniazid
PZA is also a prodrug, activated inside the bacteria by pyrazinamidase , coded by PncA gene forming pyrazinoic acid
Why does it take so long to treat TB
TB therapy takes 6 months to treat as it grows rapidly forming biofilms inside granulomas
Initial rapid kill curve by sterilising effect of INH
There is a second persistent population who no longer are turning over their cell walls and their metabolic pathways are slowed down thus the prodrugs aren’t activated - thus becoming drug tolerant
What factors impact response to treatment
Due to many host factors
Disease type and extent meningeal, bone lung TB
Immuno-competence
Bacterial strain
Genotype-phenotype
Antibiotic resistance
What increases the chance of a patient having drug resistant TB
Patient has spent time with someone with active drug-resistant TB disease
Patient does not take their medicine regularly or does not take all of their medicine
Patient develops active TB disease after having taken TB medicine in the past
Patient comes from area of the world where drug-resistant TB is common
What is MDR and XDR
Moderately and extremely drug resistant
What is the difference between MDR-TB and XDR TB
MDR-TB = resistant to INH and RIF (RH)
XDR-TB is MDR-TB resistant to any fluroquinolone (levofloxacin, moxifloxacin and ofloxacin) and at least one of three injectable second-line drugs (capreomycin, kanamycin and amikacin)
What are TB drug resistance mechanisms
Barrier mechanisms - decreased permeability and efflux pump
Degrading or inactivating enzymes - e.g. β- lactamases
Modification of pathways involved in drug activation or drug metabolism
E.g. katG and isoniazid resistance
Drug target modification - e.g. rpoB and rifampicin resistance
Target amplification - e.g. inhA and isoniazid resistance
Too much enzyme that IZH cannot fully target